MarketsStocksMANKIND
MA

Mankind Pharma Ltd

NSE: MANKINDBSE: 543904Healthcare
Download Research Report7-page PDF
2,355.00
+0.81%
NSE · auto-updates while market open
Prev Close
₹2,352.40
Day High
₹2,381.70
Day Low
₹2,299.00
Mkt Cap
₹97,993 Cr
P / E
50.6
P / B
6.0
ROE
12.7%
52W High
₹2,716.50
52W Low
₹1,909.70
Key Metrics
Market Cap
₹97,993 Cr
P / E
50.57
P / B
6.01
EV / EBITDA
29.32
ROCE
13.0%
ROE
12.7%
Debt / Equity
0.39
Book Value
₹394.87
EPS
₹46.35
Div Yield
0.0%
Face Value
₹1
Promoter Holding
72.7%
Revenue · ₹ Cr
8.7k
FY23
10k
FY24
12k
FY25
14k
FY26
Net Profit · ₹ Cr
1.3k
FY23
1.9k
FY24
2.0k
FY25
1.9k
FY26
EPS · ₹ per share
₹32.0
FY23
₹47.8
FY24
₹49.3
FY25
₹46.4
FY26
P / E Ratio · price ÷ TTM EPS
3847566560280-4May 23May 24May 25Jun 26
P/E 50.9×Median 50.5×TTM EPS
Q1 2026 snapshot
Sales
₹3.56K Cr
Operating profit
-
OPM
-
Net profit
₹559 Cr
EPS
₹13.44
Scorecard · 7 axes
Quality
Good
66/100
Valuation
Weak
50.6×
Growth
Good
+15.0%
Profitability
Avg
12.8%
Performance
Bad
-1.0%
Entry Point
Avg
87%
Red Flags
Strong
0 flags
Shareholding Pattern
72.7%Promoter
Promoter72.7%
FII10.2%
DII14.5%
Public2.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue3,2303,330.73,650.233,789.033,639.953,557.22
Net Profit384.52424.65444.62520.18413.88559.42
NPM %11.9%12.7%12.2%13.7%11.4%15.7%
AlertPre-trade